Canadian MIREC Cohort Paper on 14 November: Endothelin Profiles Measured in 1,626 Third-Trimester Plasma Samples, Median ET-1 of 4.74 pmol/mL

Researchers at Health Canada's Environmental Health Science and Research Bureau and the University of Ottawa published a paper in Biomedicines on 14 November analysing endothelin profiles in maternal plasma from the Maternal-Infant Research on Environmental Chemicals (MIREC) study, using an optimised HPLC-fluorescence method.
Stabilised third-trimester plasma from 1,626 participants was analysed for ET-1, ET-2, ET-3, BET-1 and BET-2, with a 22-minute run time. Overall analytical precision was a coefficient of variation of 6.5% or less and accuracy above 92%, with intra-day and inter-day variations of about 8.4% and 11.1% or less. Plasma ET-1 levels in the cohort were 1.65 pmol/mL at the 25th percentile, a median of 4.74, and 16.32 at the 75th percentile.
ET-1 was positively correlated with BET-1, ET-2, ET-3, the ET-1 to BET-1 ratio and vascular endothelial growth factor (VEGF), all at p less than 0.0001. Directionality changes were observed between ET-1 and VEGF in low versus high ET-1 groups. The authors said the interrelations may point to plausible compensatory vascular mechanisms in pregnancy that require further verification.
MIREC is a pan-Canadian longitudinal pregnancy cohort recruited during the first trimester from ten cities across Canada. The authors said the findings warrant use of the fast, reliable endothelin analysis approach in future larger cohort studies and advance understanding of vascular mechanisms underlying adverse pregnancy outcomes.
Published by GSM · USA (original Chinese edition)
Photo: Wikimedia Commons, File:PDB 1edn EBI.jpg — Author: Jawahar Swaminathan and MSD staff at the European Bioinformatics Institute. Licensing: Public domain.

